What’s Next? Five Things To Look Out For In December
Key Trial Kicks Off For Viatris; US Treanda Generics Set To Debut
In a busy final month of the year, key legal action will be heard in both the US and Europe, while the Medicines Patent Pool will hear from applicants for a milestone voluntary licensing agreement covering Novartis’ nilotinib.
